BeyondSpring Inc.

NASDAQ:BYSI

Biotechnology

Healthcare
$1.25 +1.58%

+$0.03 today

Market cap
$51.40M
Beta
0.42
P/E (TTM)
-8.7
EPS (TTM)
-$0.19
52W Low $1.18High $3.28

Volume 0.01M

Average 0.02M

BYSI Other Financing Activities

Financing cash flows not reported separately.

BeyondSpring Inc.NASDAQ: BYSI

Other Financing Activities · Q1 FY2026 · quarter ended Mar 2026

Other financing activities outflow grows to $0

Q1 FY2026 other financing activities was $0, compared with $0 a year earlier. Trailing-twelve-month other financing activities was $283.51K.

Context

  • Other financing activities increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other financing activities holds near $0 or moves back toward the trailing-twelve-month quarterly average of $70.88K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0+100.0% QoQ
Last fiscal yearDec 2025
$0-100.0% YoY
LTMMar 2026
$283.51K— YoY
Other Financing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-100.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Financing Activities history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
-100.0%

Other Financing Activities vs competitors

How BYSI compares with its peers on the latest reported figures

  • Peers report in different currencies, so other financing activities is compared through growth and share of revenue rather than absolute size.
BYSI Competitors
Other Financing Activities for BYSI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026$14.95M USD-79.3%—380.0%
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026$923K USD+435.6%+49.5%—
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$360.02K CAD+32.9%—2.0%
BYSIBeyondSpring Inc.LTM Mar 2026$283.51K USD———
ATYRaTyr Pharma, Inc.LTM Mar 2026$98K USD-2.0%—51.6%
BMEABiomea Fusion, Inc.LTM Mar 2026$3K USD-100.2%——
ALXOALX Oncology Holdings Inc.LTM Mar 2026$1K USD-100.0%——
DTILPrecision BioSciences, Inc.LTM Mar 2026$0 USD-100.0%—0.0%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 USD+100.0%——
Peer median (excluding BYSI) —-40.7%+49.5%26.8%

Competitors are the stored peer set for BYSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(68.21M)(36.28M)(21.03M)(11.12M)(8.47M)
Depreciation & Amortization61K232K302K285K87K
Deferred Income Tax(1.2M)0000
Stock-Based Compensation3.15M1.67M554K2.06M0
Change in Working Capital18.41M6.41M2.71M(1.38M)(376K)
Accounts Receivables(1.77M)0000
Inventory1.77M0186K(19K)(18K)
Accounts Payables(560K)(575K)00(76K)
Other Working Capital18.97M6.98M2.52M(1.36M)(282K)
Other Non-Cash Items546K(178K)988K(6.29M)(11.26M)
Operating Cash Flow(47.24M)(28.15M)(16.47M)(16.44M)(20.02M)
Capital Expenditures(2.84M)(34K)(100K)(224K)(50K)
Acquisitions (Net)20.41M00010.05M
Purchases of Investments(44.23M)(32.2M)00(14.95M)
Sales of Investments26.66M49.76M0018.43M
Other Investing Activities(20.41M)717K0(11.79M)0
Investing Cash Flow(20.41M)18.25M(100K)(12.01M)13.48M
Debt Repayment0(1.57M)03.91M286K
Common Stock Issued39K0001.99M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(38K)5M4K22.87M0
Financing Cash Flow1K3.43M4K26.79M2.27M
Effect of Forex Changes(258K)(756K)(76K)(33K)9.13M
Net Change in Cash(67.91M)(7.23M)(16.65M)(1.7M)4.86M
Free Cash Flow(50.09M)(28.19M)(16.57M)(16.67M)(20.07M)

BeyondSpring Inc.

NASDAQ:BYSI

Intrinsic Alpha fair value

Locked

Current Price

$1.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.